{"id":499649,"date":"2021-05-28T07:03:24","date_gmt":"2021-05-28T11:03:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/"},"modified":"2021-05-28T07:03:24","modified_gmt":"2021-05-28T11:03:24","slug":"zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/","title":{"rendered":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK and SAN DIEGO, May  28, 2021  (GLOBE NEWSWIRE) &#8212; Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:30 p.m. ET.<\/p>\n<p>A live webcast from the Jefferies fireside chat will be accessible through the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aDm9T2hHbK08GTSujEH0jbuXYFywEdsEzdO_DsT0_ymaD0rbrDP-HqhMJrYbJIosA-3796vl_ssSul_IRwj0Kw==\" rel=\"nofollow noopener\" target=\"_blank\">www.zentalis.com<\/a>. Following the event, an archived webcast will be available on the Zentalis website.<\/p>\n<p>\n        <strong>About Zentalis <\/strong>\n      <\/p>\n<p>Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company is developing a broad pipeline of potentially best-in-class oncology candidates, including ZN-c5, an oral selective estrogen receptor degrader (SERD) for ER+\/HER2- breast cancer, ZN-c3, a WEE1 inhibitor, ZN-d5, a BCL-2 inhibitor and ZN-e4, an EGFR inhibitor. Zentalis has operations in both New York and San Diego.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aDm9T2hHbK08GTSujEH0jaK8mLB8quJeUeJLX0yaR0EoUQukxEjjdkSuajhh8gyRJzRm0ik1_rcTZyCD3UitLqM-exYfEZVFwaI0r3Eac_VD8FkjxCrfnJOf7dvOsF5JNMse389c_65-7_8exS44PPGo1BINJ-7kUgPOlCZTmBLWXy3-iNr6rw_zkk9x9J36pGg2-STxIt_f7oXiPoZwsp6ntW7lgaLirTMZzy-RdDxXihA-u3toYSxKuOQFnPP9V5taIxL9W1b0ay3V-_mmR7WvdMhIjlkkAEOpao0BV-oTS9K4L8HlCtTWeJ9OzLLRGff79XarNnRX8SgPyCnYoyTQE-urjysD6F0rnVu-EPEU30BNv89_Pys5S73B2M4kkSvOwiln3VM1lqu2al4MnMxV3u2afkclVNLXBAr0E0I=\" rel=\"nofollow noopener\" target=\"_blank\">www.zentalis.com<\/a>. Follow Zentalis on Twitter at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z4de8T2iBwYGzZxhmQZC7GIN77I8p76w9HIkz8h8OqcDcVzUgJ8jLmfOb7Nb07265fo8rQrh6tiskBnsBr3SxDNngveJraM7eU5j8EvFIgj228Ypja_BzaCwulyk4oeehEj9DxFMpd2lriRQSL4NJBEU8SwJ3WotWjS1IOGfjGTysefQcHiXiGbZulAdEcaegBu6sJMUDeQiem4bhkTQTBWwqcGcwFEw8qbEXqiqB3rpZuG0K3iYcU92y3ZnZRHtPJGbptEuVskAaVzww51hO3Tcv1x7m4kVZCYNZE02LzH2RuUu9xHW6mlHS4s7ko7B-OQITIERJnZRj51Nk68oQmG5h5PsfKxW9CRL1i3aLpSY-bl-scGo1QDExZTMCILMd8Y7RV7_fzJVgDFSthITmOAB6CxdXlBSxdSNigpzPKc=\" rel=\"nofollow noopener\" target=\"_blank\">@ZentalisP<\/a>\u00a0and on LinkedIn at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tjy5AkGCbj-BXytYxhaarj9AWnXUe7nUcYXkAO9HlSmq61WMAtO6xsrs7sqR1YGpQIngREnjJ65lWjgmKWQI-nk67gdMHLeEX_RtZXslQOn3yMAnwiuRzYWqsvbu4BB-8hdfntqMAYQIxDAzN8EZHf5X_p3Dp0ggu_FKagtgQwB1UKNhcy6IXrtqjp8jcxuv0MquvFQOujZv3OvJA-QywmPRmeC3n1HeYr3rCbpfse1l8OhvVXivvKQXe40ggo4XaMkP8a7f1Fow-JWEjXMbNIWsSRXHC7XWkngQLsrouUybgRBCn6V-EnhBuuSCxaAMuoqFbpC_xHYVv6P8jIEDT3FypUvHnm1MxpN9rolrvKeHcew58kOAw8zsqdtimWnI\" rel=\"nofollow noopener\" target=\"_blank\">www.linkedin.com\/company\/zentalis-pharmaceuticals<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our participation in upcoming events and presentations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to the important factors discussed under the caption \u201cRisk Factors\u201d in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 filed with the U.S. Securities and Exchange Commission (SEC) and our other filings with the SEC. Any such forward-looking statements represent management\u2019s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Gitanjali Jain<br \/>Solebury Trout<br \/>1.646.378.2949<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xIvWVe9yTXbYqHWbxEzPpqxL_6nFnK7SUXPA280eTr4fF8woaaf5FsldQ-OlAUKDVPt2UqLa5Tu-KHdZs_iVzQ4vydQy0GQXgTTah9QtR48=\" rel=\"nofollow noopener\" target=\"_blank\">gogawa@soleburytrout.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong>\n      <\/p>\n<p>Julia Deutsch<br \/>Solebury Trout<br \/>1.646.378.2967<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nUOi9C8yFdNV9XKz0yShZcG19VmIRp65utVcPAse_wlHwBnAEdU3nGoSjOcgZ9rJLBMHM-111zvqvFYE8fbArPFULkNuR7VutdVOV0Ni0BlEHHOXQXxvyomAgXWZvwB9\" rel=\"nofollow noopener\" target=\"_blank\">jdeutsch@soleburytrout.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/21175825-970c-49fe-8590-f65f4812b700\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and SAN DIEGO, May 28, 2021 (GLOBE NEWSWIRE) &#8212; Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:30 p.m. ET. A live webcast from the Jefferies fireside chat will be accessible through the Investors section of the Company\u2019s website at www.zentalis.com. Following the event, an archived webcast will be available on the Zentalis website. About Zentalis Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499649","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and SAN DIEGO, May 28, 2021 (GLOBE NEWSWIRE) &#8212; Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:30 p.m. ET. A live webcast from the Jefferies fireside chat will be accessible through the Investors section of the Company\u2019s website at www.zentalis.com. Following the event, an archived webcast will be available on the Zentalis website. About Zentalis Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical &hellip; Continue reading &quot;Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-28T11:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference\",\"datePublished\":\"2021-05-28T11:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/\"},\"wordCount\":420,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/\",\"name\":\"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\",\"datePublished\":\"2021-05-28T11:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk","og_description":"NEW YORK and SAN DIEGO, May 28, 2021 (GLOBE NEWSWIRE) &#8212; Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis and Melissa Epperly, MBA, Chief Financial Officer of Zentalis, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:30 p.m. ET. A live webcast from the Jefferies fireside chat will be accessible through the Investors section of the Company\u2019s website at www.zentalis.com. Following the event, an archived webcast will be available on the Zentalis website. About Zentalis Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical &hellip; Continue reading \"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-28T11:03:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference","datePublished":"2021-05-28T11:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/"},"wordCount":420,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/","name":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=","datePublished":"2021-05-28T11:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NDU2NCM0MjA1ODI2IzIxOTQ3NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zentalis-pharmaceuticals-to-participate-in-the-jefferies-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zentalis Pharmaceuticals to Participate in the Jefferies Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499649"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499649\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}